• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰头切除术治疗 Vater 壶腹癌——长期预后较好,但术后并发症更多。

Pancreatic head resection for carcinoma of the ampulla vateri - better long-term prognosis, but more postoperative complications.

机构信息

Department of General- and Visceral Surgery, University of Freiburg Medical Center, Faculty of Medicine, Freiburg, Germany.

Current address: Clinic for General-, Visceral- and Vascular Surgery, Fürst-Stirum-Klinik, Bruchsal, Germany.

出版信息

Langenbecks Arch Surg. 2024 Apr 17;409(1):129. doi: 10.1007/s00423-024-03319-7.

DOI:10.1007/s00423-024-03319-7
PMID:38632147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11024026/
Abstract

BACKGROUND

Pancreatoduodenectomies are complex surgical procedures with a considerable morbidity and mortality even in high-volume centers. However, postoperative morbidity and long-term oncological outcome are not only affected by the surgical procedure itself, but also by the underlying disease. The aim of our study is an analysis of pancreatoduodenectomies for patients with pancreatic ductal adenocarcinoma (PDAC) and ampullary carcinoma (CAMP) concerning postoperative complications and long-term outcome in a tertiary hospital in Germany.

METHODS

The perioperative and oncological outcome of 109 pancreatic head resections performed for carcinoma of the ampulla vateri was compared to the outcome of 518 pancreatic head resections for pancreatic ductal adenocarcinoma over a 20 year-period from January 2002 until December 2021. All operative procedures were performed at the University Hospital Freiburg, Germany. Patient data was analyzed retrospectively, using a prospectively maintained SPSS database. Propensity score matching was performed to adjust for differences in surgical and reconstruction technique. Primary outcome of our study was long-term overall survival, secondary outcomes were postoperative complications and 30-day postoperative mortality. Postoperative complications like pancreatic fistula (POPF), postpancreatectomy hemorrhage (PPH) and delayed gastric emptying (DGE) were graded following current international definitions. Survival was estimated using Kaplan Meier curves and log-rank tests. A p-value < 0.05 was considered statistically significant.

RESULTS

Operation time was significantly longer in PDAC patients (432 vs. 391 min, p < 0.001). The rate of portal vein resections was significantly higher in PDAC patients (p < 0.001). In CAMP patients, a pancreatogastrostomy as reconstruction technique was performed more frequently compared to PDAC patients (48.6% vs. 29.9%, p < 0.001) and there was a trend towards more laparoscopic surgeries in CAMP patients (p = 0.051). After propensity score matching, we found no difference in DGE B/C and PPH B/C (p = 0.389; p = 0.517), but a significantly higher rate of clinically relevant pancreatic fistula (CR-POPF) in patients with pancreatoduodenectomies due to ampullary carcinoma (30.7% vs. 16.8%, p < 0.001). Long-term survival was significantly better in CAMP patients (42 vs. 24 months, p = 0.003).

CONCLUSION

Patients with pancreatoduodenectomies due to ampullary carcinomas showed a better long-term oncological survival, by reason of the better prognosis of this tumor entity. However, these patients often needed a more elaborated postoperative treatment due to the higher rate of clinically relevant pancreatic fistula in this group.

摘要

背景

胰十二指肠切除术是一种复杂的手术,即使在高容量中心,其发病率和死亡率也相当高。然而,术后发病率和长期肿瘤学结果不仅受手术本身的影响,还受基础疾病的影响。我们研究的目的是分析德国一家三级医院因胰头腺癌(PDAC)和壶腹癌(CAMP)行胰十二指肠切除术患者的术后并发症和长期结果。

方法

比较了 2002 年 1 月至 2021 年 12 月期间,109 例因壶腹 Vater 癌行胰头切除术与 518 例因胰腺导管腺癌行胰头切除术的围手术期和肿瘤学结果。所有手术均在德国弗赖堡大学医院进行。使用前瞻性维护的 SPSS 数据库回顾性分析患者数据。采用倾向评分匹配来调整手术和重建技术的差异。我们研究的主要结果是长期总体生存率,次要结果是术后并发症和 30 天术后死亡率。根据当前国际定义,对术后并发症(如胰瘘、胰腺术后出血和胃排空延迟)进行分级。使用 Kaplan-Meier 曲线和对数秩检验估计生存率。p 值<0.05 被认为具有统计学意义。

结果

PDAC 患者的手术时间明显更长(432 分钟 vs. 391 分钟,p<0.001)。PDAC 患者门静脉切除率明显更高(p<0.001)。与 PDAC 患者相比,CAMP 患者更常采用胰胃吻合术作为重建技术(48.6% vs. 29.9%,p<0.001),并且 CAMP 患者的腹腔镜手术比例呈上升趋势(p=0.051)。经过倾向评分匹配后,我们发现胰十二指肠切除术患者的 DGE B/C 和 PPH B/C 差异无统计学意义(p=0.389;p=0.517),但壶腹癌患者的临床相关胰瘘(CR-POPF)发生率明显更高(30.7% vs. 16.8%,p<0.001)。CAMP 患者的长期生存率明显更好(42 个月 vs. 24 个月,p=0.003)。

结论

因壶腹癌而行胰十二指肠切除术的患者,由于该肿瘤实体的预后较好,其长期肿瘤学生存情况明显更好。然而,由于该组患者临床相关胰瘘的发生率较高,因此他们通常需要更复杂的术后治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de74/11024026/685b66ae697d/423_2024_3319_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de74/11024026/54589ea9648b/423_2024_3319_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de74/11024026/fc927a3db363/423_2024_3319_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de74/11024026/66212003c665/423_2024_3319_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de74/11024026/685b66ae697d/423_2024_3319_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de74/11024026/54589ea9648b/423_2024_3319_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de74/11024026/fc927a3db363/423_2024_3319_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de74/11024026/66212003c665/423_2024_3319_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de74/11024026/685b66ae697d/423_2024_3319_Fig4_HTML.jpg

相似文献

1
Pancreatic head resection for carcinoma of the ampulla vateri - better long-term prognosis, but more postoperative complications.胰头切除术治疗 Vater 壶腹癌——长期预后较好,但术后并发症更多。
Langenbecks Arch Surg. 2024 Apr 17;409(1):129. doi: 10.1007/s00423-024-03319-7.
2
Perioperative and Oncological Outcomes of Robotic Versus Open Pancreaticoduodenectomy in Low-Risk Surgical Candidates: A Multicenter Propensity Score-Matched Study.低危手术患者机器人胰十二指肠切除术与开腹胰十二指肠切除术的围手术期和肿瘤学结局:一项多中心倾向评分匹配研究。
Ann Surg. 2023 Apr 1;277(4):e864-e871. doi: 10.1097/SLA.0000000000005160. Epub 2021 Aug 19.
3
Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP.新辅助治疗胰腺导管腺癌:使用 ACS-NSQIP 的术后并发症倾向匹配分析。
Ann Surg Oncol. 2021 Jul;28(7):3810-3822. doi: 10.1245/s10434-020-09460-z. Epub 2021 Jan 1.
4
Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study.在一项回顾性队列研究中,腹腔镜辅助胰十二指肠切除术治疗导管腺癌的肿瘤学结果。
Int J Surg. 2018 Jul;55:162-166. doi: 10.1016/j.ijsu.2018.05.026. Epub 2018 May 25.
5
Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.腹腔镜与开腹胰腺切除术治疗导管腺癌:胰体尾切除术和胰十二指肠切除术的独立倾向评分匹配分析。
BMC Cancer. 2021 Apr 9;21(1):382. doi: 10.1186/s12885-021-08117-8.
6
Efficacy of the two-parts wrapping technique in reducing postoperative complications in laparoscopic pancreaticoduodenectomy.两部分包裹技术在降低腹腔镜胰十二指肠切除术后并发症中的疗效。
Surg Endosc. 2024 Aug;38(8):4731-4744. doi: 10.1007/s00464-024-11028-x. Epub 2024 Jul 15.
7
[Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].[壶腹癌和胰腺癌的外科治疗结果及其R0切除术后的预后参数]
Zentralbl Chir. 2005 Aug;130(4):353-61. doi: 10.1055/s-2005-836794.
8
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.新辅助治疗与胰腺癌直接手术切除:术后并发症的实际情况和临床负担。
Ann Surg Oncol. 2018 Mar;25(3):626-637. doi: 10.1245/s10434-017-6281-9. Epub 2017 Dec 6.
9
Pancreatic head resection with segmental duodenectomy: safety and long-term results.胰头切除联合十二指肠节段切除术:安全性及长期结果
Ann Surg. 2007 Dec;246(6):923-8; discussion 929-31. doi: 10.1097/SLA.0b013e31815c2a14.
10
Robotic distal pancreatectomy reduces pancreatic fistula in patients without visceral obesity as compared to open distal pancreatectomy: A propensity score matching retrospective cohort study.机器人辅助远端胰腺切除术与开腹远端胰腺切除术相比,可减少非肥胖型内脏患者的胰瘘:一项倾向评分匹配回顾性队列研究。
Int J Surg. 2021 Jun;90:105960. doi: 10.1016/j.ijsu.2021.105960. Epub 2021 May 12.

引用本文的文献

1
Relevance of the International Study Group of Pancreatic Surgery and the Dutch Pancreatic Cancer Group Classifications of Pancreas-Specific Risk Factors in Predicting Clinically Relevant Postoperative Pancreatic Fistula in the Whipple Procedure.国际胰腺外科学研究组和荷兰胰腺癌研究组的胰腺特异性危险因素分类在预测Whipple手术中临床相关术后胰瘘方面的相关性。
Cureus. 2025 May 13;17(5):e84051. doi: 10.7759/cureus.84051. eCollection 2025 May.

本文引用的文献

1
Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study.壶腹周围局部复发性肿瘤治疗中挽救性手术的疗效:一项胰腺2000/EPC研究
Surgery. 2023 May;173(5):1254-1262. doi: 10.1016/j.surg.2022.12.011. Epub 2023 Jan 13.
2
[Ampullary Carcinoma-prognostic and Therapeutical Contrast to Pancreatic Ductal Adenocarcinoma].[壶腹癌与胰腺导管腺癌的预后及治疗对比]
Zentralbl Chir. 2022 Apr;147(2):160-167. doi: 10.1055/a-1775-9024. Epub 2022 Apr 4.
3
Survival after curative pancreaticoduodenectomy for ampullary adenocarcinoma in a South American population: A retrospective cohort study.
南美洲人群壶腹腺癌根治性胰十二指肠切除术后的生存情况:一项回顾性队列研究。
World J Gastrointest Surg. 2022 Jan 27;14(1):24-35. doi: 10.4240/wjgs.v14.i1.24.
4
Pancreatic cancer in 2021: What you need to know to win.2021 年胰腺癌:赢得胜利需要了解的知识。
World J Gastroenterol. 2021 Sep 21;27(35):5851-5889. doi: 10.3748/wjg.v27.i35.5851.
5
Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges.壶腹癌:一种罕见实体的概述及对当前和未来治疗挑战的讨论。
Curr Oncol. 2021 Sep 1;28(5):3393-3402. doi: 10.3390/curroncol28050293.
6
[Ampullary neoplasms: surgical management].壶腹肿瘤:手术治疗
Chirurg. 2021 Sep;92(9):796-802. doi: 10.1007/s00104-021-01457-y. Epub 2021 Jul 13.
7
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis.胰腺癌流行病学研究进展:趋势、风险因素、筛查和预后。
Cancer Lett. 2021 Nov 1;520:1-11. doi: 10.1016/j.canlet.2021.06.027. Epub 2021 Jun 30.
8
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.胰腺癌流行病学:了解生活方式和遗传风险因素的作用。
Nat Rev Gastroenterol Hepatol. 2021 Jul;18(7):493-502. doi: 10.1038/s41575-021-00457-x. Epub 2021 May 17.
9
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
10
[Complication management after bile duct surgery].[胆管手术后的并发症管理]
Chirurg. 2020 Jan;91(1):29-36. doi: 10.1007/s00104-019-01059-9.